Back
Delta Air Lines, Inc. Vs. Akero Therapeutics, Inc. Industry Stock Comparison
Buy
74
DAL
Delta Air Lines, Inc.
Last Price:
$70.49
Seasonality Move:
-4.69%
Buy
55
AKRO
Akero Therapeutics, Inc.
Last Price:
$54.65
Seasonality Move:
1.27%
Buy
74
Delta Air Lines, Inc. (DAL)
is a Buy
Is Delta Air Lines, Inc. a Buy, Sell or Hold?
-
The current Delta Air Lines, Inc. [DAL] share price is $70.50. The Score for DAL is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
DAL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Akero Therapeutics, Inc. (AKRO)
is a Buy
Is Akero Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Akero Therapeutics, Inc. [AKRO] share price is $54.65. The Score for AKRO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DAL Stock Price Chart
What is Delta Air Lines, Inc.'s stock price today?
-
The Delta Air Lines, Inc. share price today is $70.50The current trend is moderately bullish and DAL is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics, Inc.'s stock price today?
-
The Akero Therapeutics, Inc. share price today is $54.65The current trend is relatively stagnant and AKRO is experiencing slight buying pressure.
DAL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.78 | Buy |
| Relative Strength Index (14 RSI): | 63.75 | Buy |
| Chaikin Money Flow: | -4809186 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.18 - 70.96) | Buy |
| Bollinger Bands (100): | (56.13 - 65.05) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.29 | Buy |
| Relative Strength Index (14 RSI): | 69.15 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.32 - 54.64) | Buy |
| Bollinger Bands (100): | (46.63 - 54.53) | Buy |
DAL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.71 | Sell |
| 20-day SMA: | 68.12 | Buy |
| 50-day SMA: | 62.61 | Buy |
| 200-day SMA: | 54.22 | Buy |
| 8-day EMA: | 70.42 | Buy |
| 20-day EMA: | 67.95 | Buy |
| 50-day EMA: | 63.23 | Buy |
| 200-day EMA: | 39.61 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.65 | Sell |
| 20-day SMA: | 54.53 | Buy |
| 50-day SMA: | 54.21 | Buy |
| 200-day SMA: | 48.49 | Buy |
| 8-day EMA: | 54.63 | Buy |
| 20-day EMA: | 54.48 | Buy |
| 50-day EMA: | 53.37 | Buy |
| 200-day EMA: | 48.02 | Buy |
Delta Air Lines, Inc. Earnings Growth & DAL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and an increase next year of $1.31 per share.
Akero Therapeutics, Inc. Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.32 per share.
Delta Air Lines, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||